Dear Colleagues,

We cordially invite you to join us at the 2nd International Online Conference on Personalized Medicine (IOCPM 2027), which will be hosted online from 20 to 21 October 2027.

Personalization to the individual’s specific condition has been integral to clinical medicine since ancient times; however, the possibilities of a truly personal approach to diagnosis and therapy have been limited. Now, in the most recent decade, interest in Personalized Medicine has exploded, with over 45,000 publications integrating advances in all biomedical sciences in every branch of medicine, toward the goals of more individualized diagnosis, therapy, and continuing care.

IOCPM 2027 will be a major forum for physicians and scientists, worldwide, to present and discuss advances at the frontier of Personalized Medicine.

IOCPM 2027 is designed to encompass the breadth and depth of topics currently most relevant to Personalized Medicine. Presentations will be channeled into four sessions:
S1. Disease Mechanisms for Personalized Medicine
S2. Personalized Diagnostics, Therapeutics, and Personalized Preventative Medicine
S3. Pharmacogenomics, Multi-Omics, and Informatics for Personalized Medicine
S4. Personalized and Precision Oncology

IOCPM 2027 will enable you to share and discuss your most recent research findings in Personalized Medicine with the vibrant global community of scientists and physicians in the field.

IOCPM 2027 will make your presentation accessible to hundreds of researchers worldwide, with the active engagement of the audience in question-and-answer sessions and discussion groups that will take place online.

The conference committee will review all submitted abstracts. The authors of accepted contributions will have their work displayed in an abstract collection. Following the conference, outstanding contributions will be invited to be submitted as a full-length paper for publication in the Journal of Personalized Medicine (ISSN: 2075-4426; CiteScore: 7.2).

IOCPM 2027 promises to be a most exciting conference, which we anticipate will become a transformative landmark in Personalized Medicine. We hope you will join us, present your work, contribute to discussions, and meet new colleagues. Together at IOCPM 2027, we will shape the future of Personalized Medicine.

Best wishes,
Prof. Dr. Kenneth P. H. Pritzker
Professor Emeritus,
Laboratory Medicine and Pathobiology;
Department of Surgery, Temerty Faculty of Medicine,
University of Toronto, Toronto, Canada
Conference Chair of the 2nd International Online Conference on Personalized Medicine

More News about MDPI Conferences

Sessions

If you do not have an account, please register at www.sciforum.net. After logging in, submit your abstract using the “Submit Abstract” button on the conference homepage. No template is required.

Abstract Requirements
1. Types of Submissions
- Accepted: Original research abstracts; systematic reviews or meta-analyses abstracts (must comply with PRISMA 2020).
- Not accepted: Narrative, scoping, comparative, perspective, opinion, or essay-style reviews

2. Content Requirements
- Length: 200–300 words
- Structure: Introduction, Methods, Results, Conclusions
- Language: Clear, publication-ready English
- Originality: Must be original and unpublished; previously published abstracts will not be considered

3. Authorship
All listed authors must have made substantial contributions to the work, participated in drafting or critically revising the abstract, and approved the final version. The submitting (presenting) author is responsible for ensuring that all co-authors have reviewed and approved the submission, including its content and authorship order.

Requests for changes to authorship (including the addition, removal, or reordering of authors) after submission must be submitted using a signed Authorship Change Form, with written consent from all affected authors. Such requests are subject to review and approval by the Conference Organizing Team. All authors share collective responsibility for the accuracy, integrity, and ethical compliance of the submitted work.

Authors may submit multiple abstracts, but only one abstract per author may be selected for an oral presentation.

Presentation Requirements
1. Each abstract must designate one presenter. To change the presenter, please contact us after you receive the oral/poster presentation invitation.
2. Only live presentations are accepted.
3. Presenters who do not attend the live session will not be eligible for awards or presentation certificates.

The slot for the oral presentation is 15 mins. We advise that your presentation lasts for a maximum of 12 mins, leaving at least 3 mins for the Q&A session.

Authors are encouraged to prepare presentations using PowerPoint or equivalent software for online display alongside their abstract. If provided, slides will be presented directly on the conference website via the Sciforum.net slide viewer and should be prepared in the same format as a traditional conference presentation of research results. All slides must be converted to PDF format prior to submission to ensure accurate online display.

Each presentation should:
- Communicate the research question or objective, methodology, key results, and scientific novelty;
- Use a clear and logical structure, typically Introduction-Methods-Results&Discussion structure (IMRaD) or a field-appropriate alternative;
- Emphasize the relevance of the work;
- Support key findings with clear figures or tables where appropriate;
- Conclude with a critical interpretation of the results and their impact.

Any request concerning abstract withdrawal should be communicated to the Conference Organizing Team as early as possible, preferably prior to final acceptance and confirmation of the conference program.

AI policy
The responsible use of generative AI tools in the preparation of abstracts, posters, and presentations is permitted; however, any such use must be clearly disclosed, specifying the tool employed and its role. Authors retain full responsibility for the accuracy and integrity of their work.

Potential Conflicts of Interest
Authors must disclose any financial, professional, or personal relationships that could reasonably be perceived as influencing the integrity, interpretation, or presentation of their work. Failure to provide accurate disclosures may result in the removal of the abstract from the conference program and associated publications.

If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.

1. Copyright Ownership
In accordance with Swiss copyright law, you, as the author, are the original creator of your work and retain full copyright ownership of your submitted abstract.

2. License Grant
By submitting your abstract for publication on the Sciforum.net platform, you grant MDPI, the platform’s publisher, a worldwide, royalty-free, non-exclusive license to:
- Publish, reproduce, and distribute the abstract online.
- Make the abstract publicly available in connection with the conference.

3. Author's Retained Rights
This license is non-exclusive. As you retain full copyright, you are free to:
- Reuse, republish, and build upon your work in any way.
- Develop the abstract into a full paper for submission to other journals or publications.
- Enter into subsequent agreements, including granting an exclusive license or transferring copyright to another publisher for a future version of the work.

4. Author's Responsibility
You remain solely responsible for complying with the policies of any other journal or publisher to which you may submit a subsequent version of your work, particularly concerning prior publication rules. MDPI and Sciforum.net bear no responsibility for any conflicts arising from your future submissions.

For information regarding sponsorship and exhibition opportunities, please click here.